Free Trial

Bright Minds Biosciences (DRUG) Competitors

Bright Minds Biosciences logo
$26.16 +0.17 (+0.65%)
Closing price 07/18/2025 04:00 PM Eastern
Extended Trading
$26.27 +0.11 (+0.42%)
As of 07/18/2025 07:35 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

DRUG vs. MGTX, GYRE, AUTL, PHAR, DAWN, ZVRA, MAZE, MRVI, IOVA, and URGN

Should you be buying Bright Minds Biosciences stock or one of its competitors? The main competitors of Bright Minds Biosciences include MeiraGTx (MGTX), Gyre Therapeutics (GYRE), Autolus Therapeutics (AUTL), Pharming Group (PHAR), Day One Biopharmaceuticals (DAWN), Zevra Therapeutics (ZVRA), Maze Therapeutics (MAZE), Maravai LifeSciences (MRVI), Iovance Biotherapeutics (IOVA), and Urogen Pharma (URGN). These companies are all part of the "pharmaceutical products" industry.

Bright Minds Biosciences vs. Its Competitors

Bright Minds Biosciences (NASDAQ:DRUG) and MeiraGTx (NASDAQ:MGTX) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their risk, valuation, analyst recommendations, profitability, media sentiment, earnings, dividends and institutional ownership.

In the previous week, MeiraGTx had 1 more articles in the media than Bright Minds Biosciences. MarketBeat recorded 1 mentions for MeiraGTx and 0 mentions for Bright Minds Biosciences. MeiraGTx's average media sentiment score of 0.55 beat Bright Minds Biosciences' score of 0.00 indicating that MeiraGTx is being referred to more favorably in the news media.

Company Overall Sentiment
Bright Minds Biosciences Neutral
MeiraGTx Positive

Bright Minds Biosciences has a beta of -6.01, indicating that its share price is 701% less volatile than the S&P 500. Comparatively, MeiraGTx has a beta of 1.24, indicating that its share price is 24% more volatile than the S&P 500.

Bright Minds Biosciences has a net margin of 0.00% compared to MeiraGTx's net margin of -484.90%. Bright Minds Biosciences' return on equity of -14.56% beat MeiraGTx's return on equity.

Company Net Margins Return on Equity Return on Assets
Bright Minds BiosciencesN/A -14.56% -14.29%
MeiraGTx -484.90%-241.05%-62.93%

Bright Minds Biosciences has higher earnings, but lower revenue than MeiraGTx. Bright Minds Biosciences is trading at a lower price-to-earnings ratio than MeiraGTx, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Bright Minds BiosciencesN/AN/A-$2.06M-$0.36-72.67
MeiraGTx$33.28M20.81-$147.79M-$2.32-3.72

40.5% of Bright Minds Biosciences shares are owned by institutional investors. Comparatively, 67.5% of MeiraGTx shares are owned by institutional investors. 42.7% of Bright Minds Biosciences shares are owned by insiders. Comparatively, 7.5% of MeiraGTx shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Bright Minds Biosciences presently has a consensus target price of $83.25, indicating a potential upside of 218.23%. MeiraGTx has a consensus target price of $24.00, indicating a potential upside of 178.42%. Given Bright Minds Biosciences' stronger consensus rating and higher possible upside, equities research analysts plainly believe Bright Minds Biosciences is more favorable than MeiraGTx.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Bright Minds Biosciences
0 Sell rating(s)
0 Hold rating(s)
7 Buy rating(s)
1 Strong Buy rating(s)
3.13
MeiraGTx
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00

Summary

Bright Minds Biosciences beats MeiraGTx on 10 of the 16 factors compared between the two stocks.

Get Bright Minds Biosciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for DRUG and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding DRUG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

DRUG vs. The Competition

MetricBright Minds BiosciencesMED IndustryMedical SectorNASDAQ Exchange
Market Cap$183.07M$2.96B$5.55B$9.41B
Dividend YieldN/A2.47%3.75%4.03%
P/E Ratio-72.6619.7528.0119.82
Price / SalesN/A300.10432.6698.27
Price / CashN/A42.5936.1658.27
Price / Book28.437.678.125.65
Net Income-$2.06M-$55.28M$3.25B$257.91M
7 Day Performance5.44%4.85%1.68%3.38%
1 Month Performance-7.20%11.70%7.30%11.11%
1 Year Performance2,155.17%3.69%32.89%18.99%

Bright Minds Biosciences Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
DRUG
Bright Minds Biosciences
2.4394 of 5 stars
$26.16
+0.7%
$83.25
+218.2%
+2,300.0%$183.07MN/A-72.66N/A
MGTX
MeiraGTx
4.163 of 5 stars
$8.89
+5.0%
$24.00
+170.0%
+84.6%$714.40M$33.28M-3.83300
GYRE
Gyre Therapeutics
0.024 of 5 stars
$7.61
+1.6%
N/A-52.3%$713.51M$105.76M380.6940
AUTL
Autolus Therapeutics
2.6512 of 5 stars
$2.65
+7.3%
$9.32
+251.7%
-44.6%$705.27M$10.12M-3.01330Positive News
PHAR
Pharming Group
2.1359 of 5 stars
$10.35
+3.5%
$30.00
+189.9%
+17.4%$704.12M$320.71M-51.75280News Coverage
Gap Up
DAWN
Day One Biopharmaceuticals
2.5917 of 5 stars
$6.93
+2.1%
$29.00
+318.5%
-57.3%$702.44M$161.92M-9.7660
ZVRA
Zevra Therapeutics
3.112 of 5 stars
$12.79
+2.1%
$23.71
+85.4%
+89.5%$699.36M$23.61M-6.7320Analyst Revision
High Trading Volume
MAZE
Maze Therapeutics
N/A$15.74
+4.6%
$23.50
+49.3%
N/A$689.41M$167.50M0.00121
MRVI
Maravai LifeSciences
3.5297 of 5 stars
$2.67
-2.2%
$6.64
+148.6%
-73.0%$679.94M$259.18M-2.34610Positive News
IOVA
Iovance Biotherapeutics
4.7495 of 5 stars
$2.01
+7.5%
$12.22
+508.1%
-73.2%$671.20M$164.07M-1.62500Analyst Downgrade
Analyst Revision
Gap Up
High Trading Volume
URGN
Urogen Pharma
4.3322 of 5 stars
$14.49
+1.8%
$32.86
+126.8%
-8.2%$668.13M$90.40M-4.56200

Related Companies and Tools


This page (NASDAQ:DRUG) was last updated on 7/19/2025 by MarketBeat.com Staff
From Our Partners